Here you will find all our clinical education resources from articles to recorded webinars, all supporting equitable access to funded medicines.
If you’re after a short piece of education, our bulletins highlight key issues that can promote team discussion and spark ideas for clinical quality improvement initiatives. Read this aHAH! moment to find out more.
This video is a recording of the live webinar hosted by Mobile Health on 7 September 2022. Asthma NZ nurse educators Bekitemba Maseko and Ann Wheat highlight the importance of asthma action plans and provide practical advice resulting from real case scenarios.
Looking for up-to-date information on asthma? You can find it here!
We’ve linked resources from multiple providers into one place so it’s easy for you to find what you need.
This editable PDF helps you to delve into the EPiC data, contemplate your prescribing, reflect on your current practice, and set goals and actions.
*New audit section*
An additional audit/CQI section allows you or your practice team to repeat the process, completing activities that may be used for Foundation Standard or the Cornerstone CQI or Equity modules.
Hospitalisation and death due to asthma are unacceptably high for Māori and Pacific peoples – and little has changed over the past 18 years. The 2020 Asthma and Respiratory Foundation NZ (ARFNZ) asthma guidelines include recommendations to improve care in Māori and Pacific peoples.
New guidelines were published in 2020, incorporating recent advances in the management of asthma and recognising inequities in asthma care experienced by Māori and Pacific peoples. This article discusses current recommendations from the Asthma & Respiratory Foundation NZ.
EPiC is a free, data-driven tool that enables users to explore individual, practice and national prescribing behaviours. Insights from EPiC data can help users to consider their practice and inform targeted interventions or quality improvement initiatives.
This guide highlights the different features in EPiC, helping you to navigate through the dashboard. Our case study provides an example of how EPiC can be used to carry out quality improvement activities.
View online or click the print-ready version.
The antihypertensive medicine Accuretic (quinapril with hydrochlorothiazide) is being withdrawn (Pfizer pulled stock from distribution on 31 October 2022).
Prescribers are advised to change patients from Accuretic to alternative medicine(s) with some urgency. Read our article for dose equivalence tables and information on switching, monitoring, co-payments and consultation fees.
Although triple therapy can reduce the risk of recurrent CVD events by at least 50 per cent over five years, the He Ako Hiringa EPiC dashboard indicates only half of people receive all three types of medicines following a CVD event. Read our latest bulletin for more on triple therapy and team-based initiatives that may help identify and prioritise patients for intensive management.
With recent funding changes to adalimumab, prescribers are being urged to change patients from Humira (the reference biological) to Amgevita (a biosimilar). We’ve collated this list of questions and answers, with links to other useful resources, to help inform your conversations with colleagues and patients.
FOCUS magazine showcases a selection of our original resources. You can use the educational content featured in FOCUS to identify and reduce barriers that prevent people from accessing the medicines they need.